02:37 PM EDT, 04/30/2024 (MT Newswires) -- Cyclacel Pharmaceuticals ( CYCC ) shares surged more than 47% after the company unveiled Tuesday a private placement of about 5 million shares and warrants, targeting gross proceeds of about $8 million.

More than 19.9 million shares traded intraday compared with a daily average of about 109,000.

GeneDx ( WGS ) reported late Monday that its Q1 adjusted net loss narrowed following a surge in revenue.

TD Cowen adjusted the company's price target to $24 from $14 while keeping its buy rating.

Shares soared 47.4% as intraday trading volume soared to over 6.18 million from a daily average of about 193,000.

ATI (ATI) reported Tuesday higher-than-expected Q1 adjusted net income and sales.

Shares jumped 16.7% as intraday trading volume climbed to more than 3.46 million versus the stock's daily average of about 1.31 million.

Price: 2.00, Change: +0.64, Percent Change: +47.13